Spore.Bio
Building a new generation of microbiological technologies
Spore.Bio has raised €30M across 3 funding rounds from 9 investors, most recently a round in Jan 2026. Based in Paris, France; active in AI. Data as of 28 Oct 2026.
Paris, Francewww.spore.bio ↗
Total raised
€30M
€30,024,323
Funding rounds
3
Investors
9
distinct backers
Active since
2023-12
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDSpore.Bio — funding by year — interactive chart.
Data table
| Spore.Bio — funding by year | |
|---|---|
| 2023 | €8.0M |
| 2025 | €22M |
| 2026 | €0 |
Signals
High confidenceRaise-next likelihood39
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood19
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-08 | Other | — | Google.Org Fund for AI in Science | View deal → |
| 2025-02-20 | Series A | €22M | 1st Kind Ventures,Existing investors,Famille C Venture,LocalGlobe,Lord David Prior,No Label Ventures+2 more | View deal → |
| 2023-12-12 | Pre-Seed | €8.0M | LocalGlobe | View deal → |
Investors
9Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Helsing€2.9BGermany · AI
- Verkor€2.4BFrance · Energy
- UiPath€1.7BRomania · AI
- ContentSquare€1.3BFrance · Software
Global coverage: FundingData